ESR1 and breast carcinoma: Of note, we were unable to identify any ER+ breast cancer cell line within the Cancer Cell Line Encyclopedia19 with both genomic loss/inactivating mutations in MAP3K1 coincident with a PIK3CA mutation (Supplementary Fig. 2).